NanoEntek Croissance future
Future contrôle des critères 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for NanoEntek.
Informations clés
n/a
Taux de croissance des bénéfices
n/a
Taux de croissance du BPA
Life Sciences croissance des bénéfices | 28.4% |
Taux de croissance des recettes | n/a |
Rendement futur des capitaux propres | n/a |
Couverture par les analystes | None |
Dernière mise à jour | n/a |
Mises à jour récentes de la croissance future
Pas de mise à jour
Recent updates
Revenues Not Telling The Story For NanoEntek, Inc. (KOSDAQ:039860) After Shares Rise 32%
Oct 10NanoEntek, Inc.'s (KOSDAQ:039860) Revenues Are Not Doing Enough For Some Investors
Aug 06NanoEntek, Inc.'s (KOSDAQ:039860) 25% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio
Mar 21Should Weakness in NanoenTek, Inc.'s (KOSDAQ:039860) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Mar 14If You Had Bought NanoEnTek (KOSDAQ:039860) Shares A Year Ago You'd Have Earned 48% Returns
Jan 26Calculating The Intrinsic Value Of NanoEnTek, Inc. (KOSDAQ:039860)
Jan 04NanoEnTek Inc.'s (KOSDAQ:039860) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Dec 14Does NanoEnTek's (KOSDAQ:039860) Statutory Profit Adequately Reflect Its Underlying Profit?
Nov 23Dans cette section, nous présentons généralement des projections de croissance du chiffre d'affaires et des bénéfices basées sur les estimations consensuelles d'analystes professionnels afin d'aider les investisseurs à comprendre la capacité de l'entreprise à générer des bénéfices. Mais comme NanoEntek n'a pas fourni suffisamment de données passées et n'a pas de prévisions d'analystes, ses bénéfices futurs ne peuvent pas être calculés de manière fiable en extrapolant les données passées ou en utilisant les prévisions des analystes.
Il s'agit d'une situation assez rare car 97% des entreprises couvertes par SimplyWall St disposent de données financières passées.
Prévisions de croissance des bénéfices et des revenus
Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
---|---|---|---|---|---|
6/30/2024 | 27,804 | -473 | -772 | 284 | N/A |
3/31/2024 | 27,060 | -2,836 | -1,881 | -701 | N/A |
12/31/2023 | 26,837 | -3,678 | -1,981 | -646 | N/A |
9/30/2023 | 26,656 | -5,043 | -2,982 | 2,739 | N/A |
6/30/2023 | 29,016 | -1,199 | -2,889 | 2,365 | N/A |
3/31/2023 | 31,574 | 2,505 | 261 | 4,780 | N/A |
12/31/2022 | 35,201 | 4,665 | 3,523 | 8,044 | N/A |
9/30/2022 | 37,711 | 7,505 | 5,403 | 6,291 | N/A |
6/30/2022 | 36,035 | 5,961 | 8,543 | 9,404 | N/A |
3/31/2022 | 34,502 | 6,028 | 7,582 | 10,337 | N/A |
12/31/2021 | 35,784 | 7,321 | 6,394 | 9,290 | N/A |
9/30/2021 | 36,107 | 6,944 | 4,689 | 7,964 | N/A |
6/30/2021 | 35,076 | 6,235 | 3,228 | 6,425 | N/A |
3/31/2021 | 34,513 | 4,463 | 1,157 | 3,132 | N/A |
12/31/2020 | 29,443 | 2,737 | 4,005 | 5,697 | N/A |
9/30/2020 | 26,319 | 3,887 | 4,511 | 6,572 | N/A |
6/30/2020 | 26,987 | 5,565 | 6,105 | 7,909 | N/A |
3/31/2020 | 28,102 | 7,182 | 7,612 | 9,377 | N/A |
12/31/2019 | 26,256 | 5,750 | 2,168 | 4,083 | N/A |
9/30/2019 | 25,388 | 4,407 | 1,510 | 3,114 | N/A |
6/30/2019 | 24,895 | 3,500 | -1,112 | 491 | N/A |
3/31/2019 | 23,851 | 2,843 | -1,047 | 515 | N/A |
12/31/2018 | 25,797 | 3,308 | 11 | 1,508 | N/A |
9/30/2018 | 25,754 | 718 | 1,506 | 3,017 | N/A |
6/30/2018 | 25,474 | 138 | 1,537 | 3,341 | N/A |
3/31/2018 | 24,895 | -658 | N/A | 2,670 | N/A |
12/31/2017 | 23,810 | -2,072 | N/A | 1,707 | N/A |
9/30/2017 | 23,080 | -7,385 | N/A | 343 | N/A |
6/30/2017 | 22,454 | -9,621 | N/A | -213 | N/A |
3/31/2017 | 22,289 | -12,957 | N/A | -1,649 | N/A |
12/31/2016 | 22,206 | -14,799 | N/A | -3,022 | N/A |
9/30/2016 | 24,877 | -11,146 | N/A | -3,706 | N/A |
6/30/2016 | 24,730 | -10,679 | N/A | -4,545 | N/A |
3/31/2016 | 25,706 | -8,777 | N/A | -4,426 | N/A |
12/31/2015 | 24,839 | -7,282 | N/A | -3,538 | N/A |
9/30/2015 | 23,548 | -3,145 | N/A | -3,585 | N/A |
6/30/2015 | 22,069 | -2,736 | N/A | -3,080 | N/A |
3/31/2015 | 19,664 | -2,745 | N/A | -1,673 | N/A |
12/31/2014 | 19,499 | -2,464 | N/A | -1,629 | N/A |
9/30/2014 | 19,097 | -2,117 | N/A | 1,053 | N/A |
6/30/2014 | 19,529 | -1,752 | N/A | 1,087 | N/A |
3/31/2014 | 19,253 | -1,035 | N/A | 976 | N/A |
12/31/2013 | 19,084 | -1,237 | N/A | 2,068 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: Insufficient data to determine if A039860's forecast earnings growth is above the savings rate (2.6%).
Bénéfices vs marché: Insufficient data to determine if A039860's earnings are forecast to grow faster than the KR market
Croissance élevée des bénéfices: Insufficient data to determine if A039860's earnings are expected to grow significantly over the next 3 years.
Chiffre d'affaires vs marché: Insufficient data to determine if A039860's revenue is forecast to grow faster than the KR market.
Croissance élevée des revenus: Insufficient data to determine if A039860's revenue is forecast to grow faster than 20% per year.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Insufficient data to determine if A039860's Return on Equity is forecast to be high in 3 years time